File:Pharmaceuticals-15-00048-g001.jpg

From Wikimedia Commons, the free media repository
Jump to navigation Jump to search

Pharmaceuticals-15-00048-g001.jpg(743 × 552 pixels, file size: 112 KB, MIME type: image/jpeg)

Captions

Captions

Deucravacitinib

Summary

[edit]
Description
English: Alternate mechanisms of JAK inhibition. Deucravacitinib inhibits TYK2 activation by interacting with the pseudokinase (JH2) domain (allosteric inhibition), while first-generation jakinibs inhibit enzymatic activity by binding to the ATP-binding (JH1) domain (competitive inhibition).
Date
Source https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779366/
Author Madison Alexander, Yiming Luo, Giorgio Raimondi, John J. O’Shea, and Massimo Gadina

Licensing

[edit]
w:en:Creative Commons
attribution
This file is licensed under the Creative Commons Attribution 4.0 International license.
You are free:
  • to share – to copy, distribute and transmit the work
  • to remix – to adapt the work
Under the following conditions:
  • attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

File history

Click on a date/time to view the file as it appeared at that time.

Date/TimeThumbnailDimensionsUserComment
current21:08, 20 December 2023Thumbnail for version as of 21:08, 20 December 2023743 × 552 (112 KB)Ozzie10aaaa (talk | contribs)Uploaded a work by Madison Alexander, Yiming Luo, Giorgio Raimondi, John J. O’Shea, and Massimo Gadina from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779366/ with UploadWizard

There are no pages that use this file.